Show simple item record

Seroprevalence of antibodies against SARS-CoV-2 in the adult population during the pre-vaccination period, Norway, winter 2020/21

dc.contributor.authorAnda, Erik Eik
dc.contributor.authorBraaten, Tonje Bjørndal
dc.contributor.authorBorch, Kristin Benjaminsen
dc.contributor.authorNøst, Therese Haugdahl
dc.contributor.authorChen, Sairah Lai Fa
dc.contributor.authorLukic, Marko
dc.contributor.authorLund, Eiliv
dc.contributor.authorForland, Frode
dc.contributor.authorLeon, David Andrew
dc.contributor.authorAskeland Winje, Brita
dc.contributor.authorKran, Anne-Marte Bakken
dc.contributor.authorKalager, Mette
dc.contributor.authorLund-Johansen, Fridtjof
dc.contributor.authorSandanger, Torkjel M
dc.date.accessioned2022-11-09T09:29:50Z
dc.date.available2022-11-09T09:29:50Z
dc.date.created2022-06-03T13:25:10Z
dc.date.issued2022
dc.identifier.citationEurosurveillance. 2022, 27):pii=2100376 (13), 1-10.
dc.identifier.issn1025-496X
dc.identifier.urihttps://hdl.handle.net/11250/3030860
dc.language.isoeng
dc.titleSeroprevalence of antibodies against SARS-CoV-2 in the adult population during the pre-vaccination period, Norway, winter 2020/21
dc.title.alternativeSeroprevalence of antibodies against SARS-CoV-2 in the adult population during the pre-vaccination period, Norway, winter 2020/21
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.source.pagenumber1-10
dc.source.volume27):pii=2100376
dc.source.journalEurosurveillance
dc.source.issue13
dc.identifier.doi10.2807/1560-7917.ES.2022.27.13.2100376
dc.identifier.cristin2029379
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Files in this item

Thumbnail
Name:
article22304.pdf
Size:
463.8Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record